M&A-led growth, $1B+ backlog and data center demand—plus margin, cash flow and leverage risks. Click for more on FPS stock.

Initial public offering listings rebounded last year, though their performance—and a government shutdown—held back some ...

Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...

After a record 2025, India’s IPO market is gearing up for Rs 2.5 lakh crore in new listings. Over 200 firms have filed or ...

Taken together, consumer discretionary and financial services raised roughly ₹1.12 lakh crore in 2025, accounting for around ...

After euphoric listings and sharp corrections, can India’s IPO market recalibrate valuations, protect retail capital, and ...

Rs 1.75 lakh crore raised, but it also killed the "quick flip." With average listing gains crashing from 30% to just 9%, retail investors are fleeing. Yet, a massive 326% return secret is hidden in ...

The fund-raise through initial public offerings hit a new high for the second year in a row. About 103 corporates raised a record ₹1.76 lakh crore through main board IPOs in 2025; this was 10 per cent ...

IPO route during the year, mobilising Rs 1,75,901 crore — around 10 percent higher than the previous peak recorded in 2024.

Market watchers flag over Rs 2.65 lakh crore pipeline, strong domestic investor support and regulatory tweaks, while warning that valuations, global cues and listing gains remain key risks ...

India's IPO market, with 365 IPOs raising ₹1.95 trillion. Despite strong fundraising, few IPOs yielded significant returns for retail investors. Anondita Medicare led with a 601% return.

Even as concerns are being raised from various corners about the fact that IPOs are now becoming a tool for OFS and providing exit to existing investors and dilution to promoters, market experts say ...